Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
2006 1
2007 2
2009 4
2010 1
2011 2
2012 6
2013 7
2014 7
2015 8
2016 4
2017 7
2018 8
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19474123

52 results
Results by year
Filters applied: . Clear all
Page 1
Ipilimumab-induced hypophysitis: MR imaging findings.
Carpenter KJ, Murtagh RD, Lilienfeld H, Weber J, Murtagh FR. Carpenter KJ, et al. AJNR Am J Neuroradiol. 2009 Oct;30(9):1751-3. doi: 10.3174/ajnr.A1623. Epub 2009 May 27. AJNR Am J Neuroradiol. 2009. PMID: 19474123 Free article.
[Ipilimumab-induced hypophysitis].
Schleder S, Schreml S, Heiss P. Schleder S, et al. Rofo. 2013 Mar;185(3):268-9. doi: 10.1055/s-0032-1325515. Epub 2012 Nov 15. Rofo. 2013. PMID: 23154861 German. No abstract available.
Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.
Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB. Min L, et al. Clin Cancer Res. 2015 Feb 15;21(4):749-55. doi: 10.1158/1078-0432.CCR-14-2353. Epub 2014 Dec 23. Clin Cancer Res. 2015. PMID: 25538262 Free PMC article.
Hyponatremia associated with Ipilimumab-induced hypophysitis.
Barnard ZR, Walcott BP, Kahle KT, Nahed BV, Coumans JV. Barnard ZR, et al. Med Oncol. 2012 Mar;29(1):374-7. doi: 10.1007/s12032-010-9794-7. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264545
Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma.
Albarel F, Gaudy C, Castinetti F, Carré T, Morange I, Conte-Devolx B, Grob JJ, Brue T. Albarel F, et al. Eur J Endocrinol. 2015 Feb;172(2):195-204. doi: 10.1530/EJE-14-0845. Epub 2014 Nov 21. Eur J Endocrinol. 2015. PMID: 25416723 Clinical Trial.
Ipilimumab-induced hypophysitis and uveitis in a patient with metastatic melanoma and a history of ipilimumab-induced skin rash.
Nallapaneni NN, Mourya R, Bhatt VR, Malhotra S, Ganti AK, Tendulkar KK. Nallapaneni NN, et al. J Natl Compr Canc Netw. 2014 Aug;12(8):1077-81. doi: 10.6004/jnccn.2014.0105. J Natl Compr Canc Netw. 2014. PMID: 25099440
[Lymphocytic hypophysitis due to ipilimumap therapy].
Thomsen HH. Thomsen HH. Ugeskr Laeger. 2012 Jun 25;174(26):1829-30. Ugeskr Laeger. 2012. PMID: 22735122 Danish.
Hypophysitis: Nursing Management of Immune-Related Adverse Events
.
Vazquez A. Vazquez A. Clin J Oncol Nurs. 2017 Apr 1;21(2):154-156. doi: 10.1188/17.CJON.154-156. Clin J Oncol Nurs. 2017. PMID: 28315541
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient.
Kaehler KC, Egberts F, Lorigan P, Hauschild A. Kaehler KC, et al. Melanoma Res. 2009 Oct;19(5):333-4. doi: 10.1097/CMR.0b013e32832e0bff. Melanoma Res. 2009. PMID: 19512947
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.
Yang JC, Hughes M, Kammula U, Royal R, Sherry RM, Topalian SL, Suri KB, Levy C, Allen T, Mavroukakis S, Lowy I, White DE, Rosenberg SA. Yang JC, et al. J Immunother. 2007 Nov-Dec;30(8):825-30. doi: 10.1097/CJI.0b013e318156e47e. J Immunother. 2007. PMID: 18049334 Free PMC article. Clinical Trial.
52 results
Jump to page
Feedback